In contrast to all that, many investors prefer to focus on companies like I-Berhad (KLSE:IBHD), which has not only revenues, ...

Over the last year, a good number of insiders have significantly increased their holdings in Recce Pharmaceuticals ...

Bittensor (TAO) is a groundbreaking protocol that aims to make machine intelligence available to everyone. As we enter 2026, TAO’s price is at $285, and this is a level that shows the effects of ...

(NYSE:ROL) share price is up 81% in the last 5 years, clearly besting the market return of around 62% (ignoring dividends).

The current price is at a 5.6% discount to NAV, which has been closing. BME has traded at a premium to NAV for long periods ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

Kurtz, who first started lobbying in Utah in 2022, believes that the Cicero Institute’s publications influenced the Trump ...

Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...

The Baking Mixes Market is experiencing steady growth, driven by rising demand for convenience foods, increasing urbanization ...

A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.